Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray and Remimazolam for Pediatric Bronchoscopy
NCT06755996Completed
- Sponsor
- Tongji Hospital
- Start
- Jan 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine (2 arms), sponsored by Tongji Hospital. Primary endpoint: Sedation success rate at 1 day. Started Jan 2025; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT06755996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06755996.